Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Enzo Biochem, Inc. (ENZB)

0.4900
+0.0443
+(9.94%)
At close: 3:42:25 PM EDT
Loading Chart for ENZB
  • Previous Close 0.4457
  • Open 0.4500
  • Bid 0.4600 x --
  • Ask 0.4900 x --
  • Day's Range 0.4400 - 0.4900
  • 52 Week Range 0.2500 - 1.2700
  • Volume 85,305
  • Avg. Volume 349,088
  • Market Cap (intraday) 25.677M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1400
  • Earnings Date Jun 11, 2025 - Jun 16, 2025
  • Forward Dividend & Yield 0.40 (88.89%)
  • Ex-Dividend Date Nov 15, 2024
  • 1y Target Est --

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

www.enzo.com

125

Full Time Employees

July 31

Fiscal Year Ends

Recent News: ENZB

View More

Performance Overview: ENZB

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ENZB
30.99%
S&P 500 (^GSPC)
6.75%

1-Year Return

ENZB
49.33%
S&P 500 (^GSPC)
8.15%

3-Year Return

ENZB
80.82%
S&P 500 (^GSPC)
28.40%

5-Year Return

ENZB
78.52%
S&P 500 (^GSPC)
93.35%

Compare To: ENZB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENZB

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    23.58M

  • Enterprise Value

    -13.58M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.80

  • Price/Book (mrq)

    0.51

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -73.25%

  • Return on Assets (ttm)

    -7.46%

  • Return on Equity (ttm)

    -12.94%

  • Revenue (ttm)

    29.09M

  • Net Income Avi to Common (ttm)

    -7.6M

  • Diluted EPS (ttm)

    -0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    40.3M

  • Total Debt/Equity (mrq)

    6.73%

  • Levered Free Cash Flow (ttm)

    -661.12k

Research Analysis: ENZB

View More

Company Insights: ENZB

Research Reports: ENZB

View More

People Also Watch